D-Glucuronic Acid-Coated Ultrasmall Bi2O3 Nanoparticles for CT Imaging

2020 ◽  
Vol 20 (8) ◽  
pp. 4638-4642
Author(s):  
Adibehalsadat Ghazanfari ◽  
Shanti Marasini ◽  
Huan Yue ◽  
Son Long Ho ◽  
Xu Miao ◽  
...  

Ultrasmall Bi2O3 nanoparticles (davg = 1.5 nm) coated with biocompatible and hydrophilic D-glucuronic acid were prepared for the first time through a simple one-step polyol process and their potential as CT contrast agents were investigated by measuring their X-ray attenuation properties. Their observed X-ray attenuation power was stronger than that of a commercial iodine CT contrast agent at the same atomic concentration, as consistent with the magnitudes of atomic X-ray attenuation coefficients (i.e., Bi > I), and much stronger at the same number density. The results indicate that the nanoparticle sample is a potential CT contrast agent.

2019 ◽  
Vol 74 (3) ◽  
pp. 286-291 ◽  
Author(s):  
Adibehalsadat Ghazanfari ◽  
Shanti Marasini ◽  
Tirusew Tegafaw ◽  
Son Long Ho ◽  
Xu Miao ◽  
...  

2014 ◽  
Vol 34 (3) ◽  
pp. 267-271
Author(s):  
Wei-Hung Liu ◽  
Yang-Kao Wang ◽  
Chi-Chang Wu ◽  
Win-Pin Deng ◽  
Kuang-Hsun Lin ◽  
...  

Abstract X-ray computed tomography (CT) is one of the most powerful non-invasive diagnostic techniques nowadays. The iodinated molecules used as CT contrast agents in the clinic have short circulation times in the body, which significantly restrict its applications. Furthermore, some patients are hypersensitive to iodine. So, researchers have made tremendous efforts to improve the property of iodine. Besides, cis-diammineplatinum (II) dichloride (cisplatin), a major chemo agent for cancer treatment, possess higher X-ray attenuation coefficient being a CT contrast agent. The incorporation of cisplatin with an iodinated agent could facilitate the quality of CT images and damage cancer cells simultaneously. To reduce toxicity of a contrast agent, polymer matrix, gelatin, was incorporated for avoiding contact with nontarget cells. In this study, we combined the iodine contrast agent, 1,3-N-bis (2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodobenzene-1,3-dicarboxamide (iohexol), with cisplatin, and then examined them in a micro CT with different X-ray tube voltages (50 kV, 80 kV, 100 kV) to find optimal scanning conditions for imaging. As expected, iohexol combined with cisplatin enhanced X-ray attenuation and image contrast. The optimal CT image could be acquired at iohexol and cisplatin concentrations of 50 mg/ml and 3 mg/ml, respectively, under 80 kV irradiation. Finally, the iohexol-cisplatin-gelatin solution was then fabricated into nanoparticles of sizes about 240 nm, which may suitable for in vivo delivery.


2014 ◽  
Vol 2 (22) ◽  
pp. 3519-3530 ◽  
Author(s):  
Gaurav Lalwani ◽  
Joe Livingston Sundararaj ◽  
Kenneth Schaefer ◽  
Terry Button ◽  
Balaji Sitharaman

Development of a novel graphene-based multimodal MRI-CT contrast agent.


2011 ◽  
Vol 38 (6Part4) ◽  
pp. 3398-3398
Author(s):  
M Bonvento ◽  
S Jambawalikar ◽  
T Button

2020 ◽  
Vol 11 (4) ◽  
pp. 889-899 ◽  
Author(s):  
Chunhui Gao ◽  
Yinghua Zhang ◽  
Yan Zhang ◽  
Shaoyong Li ◽  
Xinlin Yang ◽  
...  

The disulfide bond-crosslinked polymer nanoparticles based on iopamidol were prepared and then surface-modified with cRGD peptide through the linkages of PEG to acquire a CT contrast agent for breast cancer-targeted imaging.


1993 ◽  
Vol 47 (4) ◽  
pp. 278-279 ◽  
Author(s):  
R.J. Gibson ◽  
C.I. Meanock ◽  
E.P.H. Torrie ◽  
T.M. Walker

Radiology ◽  
1999 ◽  
Vol 210 (3) ◽  
pp. 829-834 ◽  
Author(s):  
David S. Gierada ◽  
Kyongtae T. Bae

Sign in / Sign up

Export Citation Format

Share Document